Joan A. Zugay

996 citations

18 papers · 812 indexed · h-index 10

Virology top 2%
- HIV Research and Treatment 13
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 16
Organic Chemistry top 10%
- Click Chemistry and Applications 7
- Carbohydrate Chemistry and Synthesis 4
Hepatology
Molecular Biology
- Biochemical and Molecular Research 2
- Chemical Synthesis and Analysis 1
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 2
Immunology
- T-cell and Retrovirus Studies 1

Co-authors: William A. Schleif Paul L. Darke Joseph P. Vacca J C Quintero Rhonda B. Levin Stacey L. McDaniel Bruce D. Dorsey E. Jill Roth
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Tetrahedron Letters (1 paper)
Partner nations: United States Japan

In The Last Decade

Joan A. Zugay

18 papers receiving 780 citations

Peers

Countries citing papers authored by Joan A. Zugay

Since Specialization

Citations

This map shows the geographic impact of Joan A. Zugay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan A. Zugay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan A. Zugay more than expected).

Fields of papers citing papers by Joan A. Zugay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan A. Zugay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan A. Zugay. The network helps show where Joan A. Zugay may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joan A. Zugay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joan A. Zugay Line = papers co-authored together Joan A. Zugay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Nonpeptidal P₂ Ligands for HIV Protease Inhibitors: Structure-Based Design, Synthesis, and Biological Evaluation Journal of Medicinal Chemistry ·Arun K. Ghosh,John Kincaid,D. Eric Walters,Yan Chen,Narayan C. Chaudhuri,Wayne J. Thompson,Chris Culberson,Paula M.D. Fitzgerald,Hee Yoon Lee,S. P. MCKEE,Chin-Hsiu Chen,Tien T. Duong,Paul L. Darke,Joan A. Zugay,William A. Schleif,Λ. Ασπιώτη-Μάγρα,I. Llorach Gaspar,Joel R. Huff	1996	79
2	Substituted alkylpyridines as P3′ ligands for the hydroxyethylpiperazine class of HIV-1 protease inhibitors: Improved pharmacokinetic profiles Bioorganic & Medicinal Chemistry Letters ·Jesús Vega,P. A. Delsart,C. Blair Zartman,Joseph P. Vacca,Stuart R. Michelson,Jiunn H. Lin,Wang Zaidu,Kari Vastag,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Paul Anderson,Joel R. Huff	1995	2
3	Thiophene derivatives as extremely high affinity P3′ ligands for the hydroxyethylpiperazine class of HIV-1 protease inhibitors Bioorganic & Medicinal Chemistry Letters ·Jesús Vega,James P. Guare,Uri Ziegele,Stuart R. Michelson,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Jiunn H. Lin,Mimatun Nasihah,Kari Vastag,Paul Anderson,Joel R. Huff	1995	6
4	Cycloalkylpiperazines as HIV-1 protease inhibitors: enhanced oral absorption Bioorganic & Medicinal Chemistry Letters ·Jesús Vega,B. Evans,Kevin F. Gilbert,P. A. Delsart,Joseph P. Vacca,Stuart R. Michelson,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Jiunn H. Lin,Wang Zaidu,Kari Vastag,Paul Anderson,Joel R. Huff	1995	17
5	Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and rates Biochemistry ·Paul L. Darke,Y Li,Susan P. Jordan,Joan A. Zugay,Jules A. Shafer,Lawrence C. Kuo	1994	62
6	Synthesis, antiviral activity, and bioavailability studies of γ-lactam derived HIV protease inhibitors Bioorganic & Medicinal Chemistry ·Randall W. Hungate,Rubito Rubito,Zhouyujie,Joseph P. Vacca,Stacey L. McDaniel,Rhonda B. Levin,Bruce D. Dorsey,James P. Guare,M. Katharine Holloway,Willie L. Whitter,Paul L. Darke,Joan A. Zugay,William A. Schleif,Emilio A. Emini,J C Quintero,I. Llorach Gaspar,I‐Wu Chen,Paul Anderson,Joel R. Huff	1994	16
7	A new hydroxyethylamine class of HIV-1 protease inhibitors with high antiviral potency and oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Gerhard Huber,Joseph P. Vacca,James P. Guare,P. A. Delsart,Stuart R. Michelson,王万涛,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Jiunn H. Lin,I‐Wu Chen,Kari Vastag,Dražen Ostović,Paul Anderson,Joel R. Huff	1994	8
8	ChemInform Abstract: The Development of Cyclic Sulfolanes as Novel and High‐Affinity P2 Ligands for HIV‐1 Protease Inhibitors. ChemInform ·Arun K. Ghosh,Maria do Socorro Carvalho,Wayne J. Thompson,Chris Culberson,M. K. HOLLOWAY,S. P. MCKEE,Chin-Hsiu Chen,Tien T. Duong,Anthony M. Smith,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Joel R. Huff,Paul Anderson	1994	3
9	L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proceedings of the National Academy of Sciences ·Joseph P. Vacca,Bruce D. Dorsey,William A. Schleif,Rhonda B. Levin,Stacey L. McDaniel,王万涛,Joan A. Zugay,J C Quintero,和成小林,E. Jill Roth	1994	420
10	Novel conformationally constrained HIV-1 protease inhibitors: rational design, enzyme inhibition, and X-ray structure of an enzyme-inhibtor complex Bioorganic & Medicinal Chemistry Letters ·Gerhard Huber,Joseph P. Vacca,Paula M.D. Fitzgerald,Paul L. Darke,M. Katharine Holloway,James P. Guare,P. A. Delsart,KK Tha,Joan A. Zugay,Jenny Wai,Paul Anderson,Joel R. Huff	1994	3
11	3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors Journal of Medicinal Chemistry ·Arun K. Ghosh,C. S. Hardison,S. P. MCKEE,Tien T. Duong,Terry A. Lyle,Hyun-Jun Jang,Paul L. Darke,Joan A. Zugay,Emilio A. Emini	1993	62
12	Cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors Journal of Medicinal Chemistry ·Arun K. Ghosh,C. S. Hardison,Hee Yoon Lee,S. P. MCKEE,Chin-Hsiu Chen,Tien T. Duong,Paul L. Darke,Joan A. Zugay,Emilio A. Emini	1993	34
13	ChemInform Abstract: Potent HIV Protease Inhibitors: The Development of Tetrahydrofuranylglycines as Novel P2‐Ligands and Pyrazine. Amides as P3‐Ligands. ChemInform ·Arun K. Ghosh,Wayne J. Thompson,M. K. HOLLOWAY,S. P. MCKEE,Tien T. Duong,D Volk,Chin-Hsiu Chen,Anthony M. Smith,Jenny Wai,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,Joel R. Huff,Paul Anderson	1993	2
14	HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimetics. PubMed ·Arun K. Ghosh,S. P. MCKEE,William M. Sanders,Paul L. Darke,Joan A. Zugay,Emilio A. Emini,William A. Schleif,J C Quintero,Joel R. Huff,Paul Anderson	1993	5
15	A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity Journal of Medicinal Chemistry ·Thomas J. Tucker,William C. Lumma,Linda S. Payne,Jenny Wai,Jacopo Volpe,Elizabeth A. Giuliani,Paul L. Darke,Jill C. Heimbach,Joan A. Zugay	1992	39
16	Stereoselective synthesis of the hydroxyethylene isostere of the HIV protease (Tyr-Pro) cleavage site Tetrahedron Letters ·Wayne J. Thompson,Richard G. Ball,Paul L. Darke,Joan A. Zugay,J. Eric Thies	1992	11
17	Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and enzyme concentration. Journal of Biological Chemistry ·Susan P. Jordan,Joan A. Zugay,Paul L. Darke,Lawrence C. Kuo	1992	42
18	ChemInform Abstract: A Series of Potent HIV‐1 Protease Inhibitors Containing a Hydroxyethyl Secondary Amine Transition State Isostere: Synthesis, Enzyme Inhibition, and Antiviral Activity. ChemInform ·Thomas J. Tucker,William C. Lumma,Linda S. Payne,Jenny Wai,Jacopo Volpe,Sara Bonzano,Paul L. Darke,Jill C. Heimbach,Joan A. Zugay,William A. Schleif,J C Quintero,Emilio A. Emini,Joel R. Huff,Paul Anderson	1992	1

About Joan A. Zugay

Joan A. Zugay is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 18 papers that have together received 812 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (13 papers), Click Chemistry and Applications (7 papers), Carbohydrate Chemistry and Synthesis (4 papers), Biochemical and Molecular Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), T-cell and Retrovirus Studies (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Virology (399 citations), Infectious Diseases (499 citations) and Organic Chemistry (320 citations). Joan A. Zugay has collaborated with scholars based in United States and Japan. Frequent co-authors include William A. Schleif, Paul L. Darke, Joseph P. Vacca, J C Quintero, Rhonda B. Levin, Stacey L. McDaniel, Bruce D. Dorsey, E. Jill Roth, Susan P. Jordan and Lawrence C. Kuo. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Bioorganic & Medicinal Chemistry and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact